Funded Startups in Bourgogne
Among the 9 most recent funded startups shown for Bourgogne, the largest disclosed round is Inventiva Pharma’s $120M on 2026-06-02, which dwarfs the rest o…
Among the 9 most recent funded startups shown for Bourgogne, the largest disclosed round is Inventiva Pharma’s $120M on 2026-06-02, which dwarfs the rest of the disclosed amounts (the next-largest is VELA’s $45M on 2024-09-24). The table also shows a tight geographic and sectoral pattern: most companies are based in Dijon or nearby Bourgogne cities (Daix, Fontaine, Fontaine-française, Saint-rémy, Mâcon), and four of the nine entries are in Biotechnology (Inventiva Pharma, Exeliom, Oncodesign, Ynsect is Agriculture and Farming rather than biotech), alongside Agriculture and Farming (Ynsect) and Consumer/IT/Transportation/Food verticals appearing only once.
Timing is another cluster: 2025 accounts for three of the nine rows (Exeliom 2025-10-21, Ekoscan Integrity 2025-04-10, Ynsect 2025-04-07), while the earliest shown is Opencell Software’s Series A on 2021-01-25. On disclosure, five of the nine rows have disclosed amounts, with two entries marked “undisclosed” or “Series Unknown” classifications (Ekoscan Integrity is “undisclosed” for amount; three companies are labeled “Series Unknown” by round type).
Most recent rounds
9 shownRelated listings
Frequently asked
What stands out in disclosed round size across the most recent Bourgogne entries?
Inventiva Pharma’s $120M disclosed round on 2026-06-02 is a clear outlier versus the rest; the next-largest disclosed amount is VELA’s $45M on 2024-09-24, with other disclosed rounds mostly in the single-digits to tens of millions (for example Novolyze at $15M on 2022-03-23 and Ynsect at $11M on 2025-04-07).
Do any sectors appear disproportionately in this Bourgogne slice?
Biotechnology appears most frequently: Inventiva Pharma (2026-06-02, $120M), Exeliom (2025-10-21, $3M), and Oncodesign (2023-10-04, $6M). Other sectors are singletons in the shown set, including Transportation (VELA, $45M on 2024-09-24) and Information Technology (Nauticoncept on 2023-05-19 for $1M; Opencell Software on 2021-01-25 for $8M).
Are the most recent closings concentrated in a short date window?
Yes—three of the nine rows are in 2025, including Exeliom on 2025-10-21 ($3M) and two April 2025 entries on 2025-04-10 (Ekoscan Integrity, undisclosed) and 2025-04-07 (Ynsect, $11M). By contrast, earlier years are less clustered, with the oldest shown closing on 2021-01-25 (Opencell Software, $8M).
How mixed is stage disclosure versus “Series Unknown,” and how does that interact with amount disclosure?
Stage labels are split: five entries are explicitly “Series A” (Exeliom 2025-10-21 $3M; VELA 2024-09-24 $45M; Novolyze 2022-03-23 $15M; Nauticoncept is “Series Unknown” though amount is $1M; Opencell Software 2021-01-25 $8M; plus others), while three are marked “Series Unknown” (Inventiva Pharma, Ekoscan Integrity, Oncodesign, and Nauticoncept each show “Series Unknown” in the table). Amount disclosure is also uneven: Ekoscan Integrity’s 2025-04-10 amount is “undisclosed,” even though most other rows show disclosed dollars (e.g., Ynsect $11M on 2025-04-07).
Which cities recur, and is any cluster visible within Bourgogne?
Dijon is the most recurrent city: Exeliom (Dijon, 2025-10-21, $3M), Oncodesign (Dijon, 2023-10-04, $6M), and Opencell Software (Dijon, 2021-01-25, $8M) all list Dijon as their location. Daix also repeats with Inventiva Pharma (Daix, 2026-06-02, $120M) and Novolyze (Daix, 2022-03-23, $15M), suggesting concentration in a small set of nearby hubs.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.